Recruiting Pulmonary Hypertension Studies in Houma
Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE
The purpose of this study is to prove the non-inferiority of a 6-weeks treatment with 1 mg budesonide orodispersible tablets BID versus 2 mg budesonide orodispesible tabletss for the induction of clin...
Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee
A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the effect of Temsirolimus Perivascular Injection 0.1 mg/mL on the incidence of ischemia-driven major amputation, clinical...
About Pulmonary Hypertension Clinical Trials in Houma
Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.
There are currently 2 pulmonary hypertension clinical trials recruiting participants in Houma, LA. These studies are seeking a combined 558 participants. Research is being sponsored by Dr. Falk Pharma GmbH, Mercator MedSystems, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Hypertension Clinical Trials in Houma — FAQ
Are there pulmonary hypertension clinical trials in Houma?
Yes, there are 2 pulmonary hypertension clinical trials currently recruiting in Houma, LA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Houma?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Houma research site will contact you about next steps.
Are clinical trials in Houma free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Houma studies also compensate for your time and travel.
What pulmonary hypertension treatments are being tested?
The 2 active trials in Houma are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary hypertension.
Data updated March 2, 2026 from ClinicalTrials.gov